Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (312) Arrow Down
Filter Results: (312) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (312)
    • People  (1)
    • News  (58)
    • Research  (211)
    • Events  (1)
    • Multimedia  (1)
  • Faculty Publications  (97)

Show Results For

  • All HBS Web  (312)
    • People  (1)
    • News  (58)
    • Research  (211)
    • Events  (1)
    • Multimedia  (1)
  • Faculty Publications  (97)
← Page 9 of 312 Results →
  • 09 Jan 2007
  • First Look

First Look: January 9, 2007

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707413 Teva Pharmaceutical Industries, Ltd. Harvard Business School Case 707-441 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707441  ... View Details
Keywords: Martha Lagace
  • 15 Jun 2007
  • Research & Ideas

Remembering Alfred Chandler

Chemical and Pharmaceutical Industries. In his lifetime, he produced a range of books, edited collections, and articles covering railways, management, global competition, anthracite coal, the career of Alfred P. Sloan, the nature of... View Details
Keywords: by Sean Silverthorne
  • 20 Oct 2011
  • Research & Ideas

Getting the Marketing Mix Right

what is called the Invariant Proportion of Substitution (IPS) property, which implies that the proportion of demand generated by taking business away from a competitor is the same, no matter which marketing activity is used. "These... View Details
Keywords: by Dina Gerdeman
  • January 2017 (Revised March 2017)
  • Case

Royal DSM: From Continuous Transformation to Organic Growth

By: William W. George, Carin-Isabel Knoop and Amram Migdal
Royal DSM CEO Feike Sijbesma was pondering the challenges of shifting DSM’s global organization from the constant transformations of the past 100 years to creating organic growth. When Sijbesma took the helm as CEO in 2007, he further pushed and completed the company’s... View Details
Keywords: Organic Growth; Organizational Change; M&A; Mergers And Acquisitions; Divestment; Business Ventures; Business Divisions; Business Growth and Maturation; Restructuring; Change; Change Management; Transformation; Transition; Engineering; Chemicals; Mining; Ethics; Values and Beliefs; Finance; Capital Markets; Financial Markets; Food; Globalization; Global Strategy; Globalized Firms and Management; Globalized Markets and Industries; Health; Nutrition; History; Leadership; Leadership Development; Leadership Style; Leading Change; Management; Business or Company Management; Growth and Development Strategy; Growth Management; Management Practices and Processes; Management Style; Organizations; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Change and Adaptation; Organizational Culture; Organizational Design; Ownership; Public Ownership; Performance; Strategy; Adaptation; Consolidation; Corporate Strategy; Value; Value Creation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Europe; Netherlands
Citation
Educators
Purchase
Related
George, William W., Carin-Isabel Knoop, and Amram Migdal. "Royal DSM: From Continuous Transformation to Organic Growth." Harvard Business School Case 317-063, January 2017. (Revised March 2017.)
  • 13 Oct 2009
  • Research & Ideas

7 Lessons for Navigating the Storm

CEO Dan Vasella made counterintuitive moves by expanding Novartis's generic drug, vaccines, and consumer health businesses in spending heavily on acquisitions to offer alternatives to patented drugs. Meanwhile, he focused Novartis's View Details
Keywords: by Martha Lagace
  • Web

Harvard Business School

and Connecticut General Insurance Corporation, where Jones became the first African American board member. Otis Gates III MBA 1963 Otis Gates grew up in Roxbury and graduated from both Harvard College and HBS. In 1968, Gates began his... View Details
  • Web

2024 Reunion Presentations - Alumni

large tech companies and retailers are making bold moves into the industry. These health care “entrants” aim to leverage their general skills in serving consumers to address barriers in health care delivery. Will these new entrants be... View Details
  • Research Summary

Overview

By: Andy Wu
How can technology entrepreneurs build competitive advantage from the ground up? Professor Andy Wu conducts scholarly research and develops course materials that document how technology entrepreneurs can (1) organize for innovation to create new market opportunities... View Details
Keywords: Strategy; Entrepreneurship; Venture Capital; Growth Management; Organizational Design; Organizational Structure; Technology Platform; Technological Innovation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; China; Southeast Asia; South Asia
  • 12 Dec 2022
  • Research & Ideas

Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them

Moderna, a pharmaceutical company, announced in September 2020 that it would slow enrollment of its COVID-19 vaccine trials to better improve representation. The majority of study participants were white, although COVID-19 was... View Details
Keywords: by Scott Van Voorhis; Pharmaceutical; Pharmaceutical
  • 10 Sep 2008
  • Research & Ideas

Long-Tail Economics? Give Me Blockbusters!

you can make money in many creative industries by selling specialized products to niche markets identified via the Internet. For example, the new CEO of GlaxoSmithKline, the pharmaceuticals giant, likens the search for blockbusters to... View Details
Keywords: by John Quelch; Pharmaceutical; Pharmaceutical
  • 01 Dec 2017
  • News

2017 in Health Care: Telemedicine Has Arrived

telemedicine services available next year to employees in states that allow it. We’re going to see a lot more investment in this area, from both established health care companies and startups. What’s next in health care? “More constraints on drug price growth. Today,... View Details
Keywords: Halle Tecco (MBA 2011), founder emeritus, Rock Health; angel investor; adjunct professor, Columbia Business School

    Melvin R. Goodes

    Goodes grew Warner-Lambert’s market value from $9 billion in 1991 to almost $60 billion in 1999. He helped the pharmaceutical company become a major player in the prescription drug industry and is responsible for striking a deal with... View Details
    Keywords: Personal Care & Home Products
    • 27 Jun 2005
    • Research & Ideas

    The Potential Downside of Win-Win

    the negotiation. In April 2001, the FTC filed a complaint accusing pharmaceutical companies Schering-Plough and Upsher-Smith of restricting trade. Upsher-Smith had been preparing to introduce a generic View Details
    Keywords: by Max H. Bazerman

      Robert P. Luciano

      Luciano generated top-level financial performance while streamlining Schering’s business operations. He divested Schering’s non-healthcare related business lines and was one of the first pharmaceutical... View Details
      Keywords: Healthcare

        E. Gifford Upjohn

        Upjohn played an instrumental role in supporting legislation requiring pharmaceutical companies to prove a drug’s effectiveness in clinical trials prior to its general release. A physician by training,... View Details
        Keywords: Healthcare
        • 01 Mar 2017
        • News

        How Deep Brain Stimulation Could Change Medicine

        engineers to tweak preexisting medical instruments or develop entirely new medical devices. The general deep brain stimulation procedure is now established practice: For over a decade, neurosurgeons have placed electrodes in the brains of... View Details
        Keywords: Janelle Nanos
        • 01 Dec 2004
        • News

        Finding a Balance

        Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that... View Details
        Keywords: Julia Hanna; Colleges, Universities, and Professional Schools; Educational Services
        • 15 Sep 2009
        • First Look

        First Look: September 15

        generation moving up the corporate ranks. Stimulate Creativity by Fueling Passion Authors:Teresa Amabile and Colin M. Fisher Publication:In The Blackwell Handbook of Principles of Organizational Behavior. 2nd ed. London: Wiley-Blackwell,... View Details
        Keywords: Martha Lagace
        • 24 Apr 2014
        • News

        Giving hope and inspiration to cancer patients around the globe

        Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details
        • 03 Dec 2001
        • Research & Ideas

        Healthcare Conference Looks At Ailing Industry

        specified stage of development. It would throw the ball over the fence [to a major pharmaceutical firm] and it would sit around and wait. Sooner or later, if the product was successful, it would collect some royalties." Now, a... View Details
        Keywords: by Martha Lagace; Health
        • ←
        • 9
        • 10
        • …
        • 15
        • 16
        • →
        ǁ
        Campus Map
        Harvard Business School
        Soldiers Field
        Boston, MA 02163
        →Map & Directions
        →More Contact Information
        • Make a Gift
        • Site Map
        • Jobs
        • Harvard University
        • Trademarks
        • Policies
        • Accessibility
        • Digital Accessibility
        Copyright © President & Fellows of Harvard College.